Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism

The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).

Trial Details

NCT ID
NCT06222606
Phase
NA
Sponsor
Aarhus University Hospital
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Surgery with autofluorescence
Locations (sample)
  • Aarhus, Denmark, Denmark|56.15674,10.21076

Key Eligibility Criteria

  • Age\>18 years and able to give informed consent.
  • Suspicion or diagnosis of thyroid cancer.
  • Planned total thyroidectomy or completion thyroidectomy.
  • Normocalcemia prior to surgery.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →